Matches in Nanopublications for { <http://bio2rdf.org/drugbank_resource:DB00675_DB00682> ?p ?o ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- drugbank_resource:DB00675_DB00682 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00675_DB00682 label "DDI between Tamoxifen and Warfarin - Tamoxifen, a CYP2C9 inhibitor, may increase the serum concentration of warfarin by decreasing its metabolism. Concomitant therapy is contraindicated due to significant increase in bleed risk. [drugbank_resource:DB00675_DB00682]" assertion.
- drugbank_resource:DB00675_DB00682 identifier "drugbank_resource:DB00675_DB00682" assertion.
- drugbank_resource:DB00675_DB00682 title "DDI between Tamoxifen and Warfarin - Tamoxifen, a CYP2C9 inhibitor, may increase the serum concentration of warfarin by decreasing its metabolism. Concomitant therapy is contraindicated due to significant increase in bleed risk." assertion.